Biochem Biophysic Res Comm 1993,190(1):302–307.CrossRef 13. Ito T, Higuchi T, Hirobe M, Hiramatsu K, GSK3235025 supplier Yokota T: Identification of a novel sugar, 4-amino-4,6-dideoxy-2-O-methylmannose in the lipopolysaccharide of Vibrio cholerae O1 serotype Ogawa. Carbohydrate Res 1994,256(1):113–128.CrossRef 14. Faruque SM, Nair GB, Mekalanos JJ: Genetics of stress adaptation and virulence in toxigenic Vibrio cholerae. DNA Cell Biol 2004,23(11):723–741.PubMedCrossRef Selleckchem mTOR inhibitor 15. Comstock LE, Johnson JA, Michalski JM, Morris JG Jr, Kaper JB: Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1.

Mole Microbiol 1996,19(4):815–826.CrossRef 16. Bhaskaran K, Gorrill RH: A study of antigenic variation in Vibrio cholerae. J Gen Microbiol 1957,16(3):721–729.PubMedCrossRef

HMPL-504 nmr 17. Sack RB, Miller CE: Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. J Bacteriol 1969,99(3):688–695.PubMed 18. Sheehy TW, Sprinz H, Augerson WS, Formal SB: Laboratory Vibrio cholerae infection in the United States. Jama 1966,197(5):321–326.PubMedCrossRef 19. Ito T, Hiramatsu K, Ohshita Y, Yokota T: Mutations in the rfbT gene are responsible for the Ogawa to inaba serotype conversion in Vibrio cholerae O1. Microbiol Immunol 1993,37(4):281–288.PubMed 20. Koelle K, Pascual M, Yunus M: Serotype cycles in cholera dynamics. Proc Rapamycin in vitro 2006,273(1603):2879–2886. 21. Ogg JE, Ogg BJ, Shrestha MB, Poudayl L: Antigenic changes in Vibrio cholerae biotype eltor serotype Ogawa after bacteriophage infection. Infect Immunity 1979,24(3):974–978. 22. Stroeher UH, Karageorgos LE, Morona R, Manning PA: Serotype conversion in Vibrio cholerae O1. Proc Nat Acad Sci USA 1992,89(7):2566–2570.PubMedCrossRef 23. Ito T, Ohshita Y, Hiramatsu K, Yokota T: Identification

and nucleotide sequence determination of the gene responsible for Ogawa serotype specificity of V. cholerae 01. FEBS letters 1991,286(1–2):159–162.PubMedCrossRef 24. Rijpkema SG, Durrani Z, Ramamurthy T, Nair GB: Assessing clonality of Vibrio cholerae Inaba isolates by characterization of nonsense mutations in wbeT. J Med Microbiol 2004,53(Pt 11):1105–1107.PubMedCrossRef 25. Felsenfeld O: A review of recent trends in cholera research and control. With an annex on the isolation and identification of cholera vibrios. Bull World Health Org 1966,34(2):161–195.PubMed 26. Longini IM Jr, Yunus M, Zaman K, Siddique AK, Sack RB, Nizam A: Epidemic and endemic cholera trends over a 33-year period in Bangladesh. J Infect Dis 2002,186(2):246–251.PubMedCrossRef 27. Wei CY: Cholera prevention and control – China, 1961–2011. J Prev Med Inf 2012,28(7):497–504. 28. Mukerjee S, Roy UK, Rudra BC: Studies on typing of cholera vibrios by bacteriophage. V. Geographical distribution of phage-types of vibrio cholerae. Annals Biochem Exp Med 1963, 23:523–530. 29.